Tresiba Coupons & Savings Card – Discount Prices from $104.15

This safety information outlines important warnings and precautions associated with the use of insulin degludec (Tresiba). It is crucial to review these points carefully and discuss any concerns with your healthcare provider.

• Infection Risk from Pen Sharing: Do not share insulin degludec (Tresiba) pens, syringes, or needles with others. Sharing these items increases the risk of transmitting serious infections and health issues.

• Blood Sugar Level Fluctuations: Alterations in your insulin regimen or injection sites can impact your body's insulin response, potentially leading to high or low blood sugar levels. Repeated injections in areas with lipodystrophy, such as pitted or thickened skin, may also cause elevated blood sugar levels.

• Hypoglycemia Risk: Insulin degludec (Tresiba), alone or in conjunction with other glucose-lowering medications, can cause hypoglycemia, a condition characterized by dangerously low blood sugar levels that can be life-threatening if untreated. Contributing factors include dietary changes, alcohol consumption, use of additional diabetes medications, liver or kidney issues, and improper use of insulin degludec (Tresiba).

• Low Potassium Levels: This medication may decrease your blood potassium levels, posing a health risk. The risk increases if you are taking other potassium-lowering medications, such as certain diuretics. Regular monitoring of potassium levels and appropriate supplementation may be necessary.

• Fluid Retention and Heart Failure: Concurrent use of insulin degludec (Tresiba) with glitazones (e.g., pioglitazone) can lead to fluid retention, which may precipitate or worsen heart failure. Symptoms include difficulty breathing and reduced exercise capacity. This risk is heightened with a history of heart failure.

• Allergic Reactions: Though rare, serious allergic reactions such as anaphylaxis can occur. Seek immediate medical attention if you experience symptoms including swelling of the lips, face, or tongue, rash, or difficulty breathing.

Contraindications:

• Insulin degludec (Tresiba) should not be used during episodes of hypoglycemia (low blood sugar). Always consult with your healthcare provider if you have any concerns or medical conditions that may contraindicate the use of this medication.

When using this medication, some common side effects may occur, though they are generally mild. These include low blood sugar levels, which can affect up to 99% of users, common cold symptoms in about 24%, upper respiratory tract infections in 12%, headaches in 12%, diarrhea in 6%, sinus infections in 5%, and stomach viral infections in 5%. Weight gain and reactions at the injection site, such as pain, redness, or irritation, may also be experienced. There can also be instances of fluid buildup and changes in the skin where the medication is injected, such as fat deposits or pitting.

While these side effects are typically manageable, there are serious side effects that require immediate attention. Severely low blood sugar can present with symptoms like dizziness, shakiness, confusion, irritability, sweating, extreme hunger, and an inability to think clearly. Dangerously low potassium levels, marked by weakness, muscle cramps, constipation, and abnormal heartbeat, are also critical. In rare cases, severe allergic reactions may occur, characterized by rash, swelling of the face, tongue, or throat, and difficulty breathing. If any of these serious symptoms arise, it is crucial to seek urgent medical care. Always discuss any persistent or concerning side effects with your healthcare provider.